Open original FDA record ↗Recall record
- FDA identifier
- Z-1877-2025
- Company in FDA record
- BioFire Diagnostics, LLC
- FDA classification date
- May 29, 2025
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Due to manufacturing error, respiratory panel may result in elevated control failures and/or false negative results.
Source facts
- Action
- On April 30, 2025, Biomerieux issued a "Urgent Field Safety Notice" to affected consignees via email. Biomerieux asked consignees to take the following actions: 1. Immediately examine your inventory for the lot identified in this field safety notice. 2. Discontinue use and discard any remaining product from this lot in your possession. 3. As previously confirmed discontinued use of product, please confirm the amount of kits destroyed on the attached Acknowledgement of Receipt Form. 4. If you have further distributed this product, please identify any recipients and notify them at once. 5. Please complete the accompanying Acknowledgement of Receipt Form and return to bioMrieux so that bioMrieux may acknowledge your receipt of this notification.
- Initiated
- 2025-04-30
- Root cause
- Under Investigation by firm
- Distribution
- International distribution in the country of Singapore.
- Recall number
- Z-1877-2025
- Recall status
- Open, Classified
- CDRH record ID
- 213749
- FDA classified
- 2025-05-29
- Recall event number
- 96835